Stemgent Sells the Stem Cell Reagent and Services Business Unit

CAMBRIDGE, Mass., Oct 01, 2014 (BUSINESS WIRE) — Stemgent Inc. announced today that it has completed the sale of its stem cell reagents and services business to ReproCELL in a cash transaction for approximately $8.5 million. Stemgent is selling the stem …

[Read the full article here]

Comments are closed.